Abstract | OBJECTIVE AND DESIGN: SUBJECTS: Male Hartley guinea pigs were used. TREATMENT: Animals were actively sensitized with ovalbumin (OVA) or Japanese cedar pollen, and were then repeatedly challenged with OVA or pollen, respectively. KP-496 (0.003 %-0.05 %) was intranasally administered 0.5 or 1 h before and 2 h after an antigen challenge. METHODS: As an indicator of nasal blockage, specific airway resistance was measured using a double-flow plethysmograph system. Statistical analyses were performed with Dunnett's test (OVA model) or t-test (pollen model). RESULTS: Although early phase response was not affected by even a high dose (0.03 %) of KP-496, late phase nasal blockage (1.68 +/- 0.26) was inhibited by 0.01 % (0.87 +/- 0.19; p <0.05) and 0.03 % (0.44 +/- 0.12; p <0.01) of KP-496 in the OVA model. On the other hand, both early (5.60 +/- 0.77) and late phase responses (7.90 +/- 1.70) were inhibited by 0.05 % KP-496 to 2.68 +/- 0.84 (p <0.05) and 2.71 +/- 0.83 (p <0.05), respectively, in the pollen model, in which nasal hyperresponsiveness had been acquired by multiple challenges. CONCLUSIONS:
|
Authors | N Mizutani, M Suda, M Ishimura, S Kurokawa, T Nabe, S Kohno |
Journal | Inflammation research : official journal of the European Histamine Research Society ... [et al.]
(Inflamm Res)
Vol. 57
Issue 6
Pg. 247-51
(Jun 2008)
ISSN: 1023-3830 [Print] Switzerland |
PMID | 18516714
(Publication Type: Journal Article)
|
Chemical References |
- Benzoates
- KP-496
- Leukotriene Antagonists
- Receptors, Leukotriene
- Receptors, Thromboxane A2, Prostaglandin H2
- Thiazoles
- Ovalbumin
- leukotriene D4 receptor
|
Topics |
- Airway Resistance
(drug effects)
- Animals
- Area Under Curve
- Benzoates
(pharmacology, therapeutic use)
- Disease Models, Animal
- Guinea Pigs
- Humans
- Leukotriene Antagonists
(pharmacology, therapeutic use)
- Male
- Nasal Mucosa
(drug effects)
- Nasal Obstruction
(immunology)
- Ovalbumin
(immunology)
- Pollen
(immunology)
- Receptors, Leukotriene
(metabolism)
- Receptors, Thromboxane A2, Prostaglandin H2
(antagonists & inhibitors)
- Rhinitis, Allergic, Perennial
(drug therapy, immunology)
- Sneezing
(drug effects)
- Thiazoles
(pharmacology, therapeutic use)
|